Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Keeping children safe on social media: What parents should know to protect their kids
Recommended
Hurricane season 2024: Beware rip current danger if you visit NC coast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acadia Pharmaceutica
(NQ:
ACAD
)
14.91
-0.18 (-1.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,488,152
Open
15.01
Bid (Size)
14.89 (1)
Ask (Size)
14.91 (46)
Prev. Close
15.09
Today's Range
14.81 - 15.12
52wk Range
14.55 - 33.99
Shares Outstanding
162,625,379
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Sorry Pharma Stocks to Sell in May While You Still Can
May 29, 2024
Discover three pharma stocks to sell in May while you still can. Avoid these companies facing significant setbacks.
Via
InvestorPlace
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24, 2024
Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications.
Via
Benzinga
Topics
Data Breach
Exposures
Information Security
Performance
YTD
-51.69%
-51.69%
1 Month
+0.40%
+0.40%
3 Month
-20.35%
-20.35%
6 Month
-48.62%
-48.62%
1 Year
-38.06%
-38.06%
More News
Read More
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome
May 15, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals
April 10, 2024
Via
Benzinga
Expert Ratings For ACADIA Pharmaceuticals
March 25, 2024
Via
Benzinga
Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar
May 09, 2024
Via
InvestorPlace
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
May 09, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
ACAD Stock Earnings: ACADIA Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
May 08, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
ACADIA Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (25 Ratings)
April 30, 2024
Via
Benzinga
Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship
April 29, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
April 24, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
April 22, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 19, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
April 17, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
3 Pharma Stocks to Sell in April Before They Crash & Burn
April 11, 2024
Via
InvestorPlace
Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development
April 02, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 01, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via
Benzinga
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
3 Pharma Stocks to Sell in March Before They Crash & Burn
March 14, 2024
Via
InvestorPlace
Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day
March 13, 2024
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Via
Benzinga
Why Are Airline Stocks Down Today?
March 12, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.